
Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a range of rare diseases, including primary immunodeficiency diseases and rare cancers.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account